New York – February 27, 2019 – Creative Biolabs, one of the few companies who can offer integrated drug discovery services for clients all over the world, launches the In Vitro Diagnostic (IVD) Antibody Development Services for a variety of disease areas including, but not limited to, autoimmune diseases, cancer, infectious diseases, and cardiovascular diseases.
As critical components of different antibody-based kits or diagnostic assays, in vitro diagnostic antibodies with high-affinity and specificity are developed against a wide range of disease biomarkers. Based on a well-established IVD Antibody Development Platform, Creative Biolabs is capable of providing a full range of customized monoclonal antibody development service and antigen & antibody conjugation service in a fast turn-around time.
Since the development of hybridoma technology, monoclonal antibodies have tremendous applications in the field of diagnostics. In addition, monoclonal antibodies are used in the diagnosis of lymphoid and myeloid malignancies, tissue typing, enzyme-linked immunosorbent assay, radio immunoassay, serotyping of microorganisms. In Creative Biolabs, the flexible and cost-effective monoclonal antibody development services are provided in a wide range of host animal species, including mice, rats, rabbits, hamsters, sheep, and chickens. Based on the hybridoma technology, the quantity of antibodies can be small size for research uses or large scale for diagnostic industry, and antibodies can be produced within only 70 days.
“Antigen and antibody conjugation service is another essential part in biological agents for targeted therapeutic studies, immunoassay or detection applications. Custom antibody conjugation in Creative Biolabs uses a monoclonal antibody or polyclonal antibody through chemical conjugation with other biomolecules. Our experienced staffs have developed standard Lightning-Link kits that can work well with all IgGs irrespective of species and will generate excellent conjugates. Moreover, antibodies can be labeled with various enzymes, fluorochromes, or biotin that generates a signal for visualization or quantitation of the target molecule,” said a scientist in Creative Biolabs.
“In addition, we provide custom conjugation of an antibody to numerous labeled materials, such as HRP, biotin or a fluorophore, either to an antibody in our catalog or as a stand-alone service for customer-supplied material. In particular, we have developed scalable processes from milligram (mg) to gram (g) quantities of conjugates. All of our IVD development services can be customized in terms of the clients’ specific requirements and be performed by our experienced scientists to offer competitive price and high-quality.”
Creative Biolabs aims to produce high-quality monoclonal antibodies of diagnostic use, thereby improving the value of these antibody-based diagnostic tools and helping clinicians in the diagnosis, prognosis, and staging of a variety of disease. If you need more information on IVD development services, please visit https://www.creative-biolabs.com/drug-discovery/diagnostics/.
About Creative Biolabs
Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, scientists in Creative Biolabs are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Creative Biolabs is able to undertake the entire discovery pipeline and also pleased to offer specific service based on clients’ requirements.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States